Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Infections × Control Groups × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 40 Neoplasms 20 Motor Activity 10 Colorectal Neoplasms 9 Pain, Postoperative 8 Lung Neoplasms 7 Fatigue 7 Stomach Neoplasms 6 Anxiety Disorders 6 Pain 4 Depression 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Sleep Initiation and Maintenance Disorders 3 Polycystic Ovary Syndrome 3 Malnutrition 3 Leukemia, Myeloid, Acute 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Stomatitis 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parasomnias 2 Ovarian Neoplasms 2 Nausea 2 Lymphedema 2

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 7 Vancomycin 4 Voriconazole 3 Fluconazole 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Therapeutics 2 Ribavirin 2 Polymerase Chain Reaction 2 Piperacillin, Tazobactam Drug Combination 2 Moxifloxacin 2 Levofloxacin 2 Lenalidomide 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Filgrastim 2 Daptomycin 2 Cefepime 2 Caspofungin 2 ziprasidone 1 tocilizumab 1 threonic acid 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06655506 2024-10-23

ERGO

National and Kapodistrian University of Athens

Infections, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡